An innovative telehealth program helps improve the short- and long-term outcomes of high-risk patients with complex congenital heart defects.
Clinical trials continue the advancement of pediatric oncology treatment
CHOC currently offers more than 140 clinical trials in varying phases, including multiple pharmaceutical industry-sponsored clinical trials.
Investigational Drug Study Leads to FDA Approval for Fenfluramine in Treatment for Dravet Syndrome
Dr. Mary Zupanc was a key investigator in a study that led to FDA approval for a medication to treat children with Dravet syndrome.
Virtual pediatric lecture series: vision screening refresher
This online discussion is designed for general practitioners, family practitioners and other healthcare providers.
MI 1&2 meeting and journal club
CHOC’s MI 1&2 Meeting & Journal Club goes virtual this month to discuss the latest advances in artificial intelligence and innovation.
CHOC rare disease expert stresses importance of newborn screening
CHOC is one of the state’s largest referral centers for the newborn screening program, which checks babies for many serious genetic disorders.
